Connect with us

Media & Technology

Strategic Asset Leasing Inc., (OTCMKTS: LEAS) Powerful Runner as RM Candidate Looks To Go Pink Current and is Acquired by Dr. J Sinkule, CEO of PHARMIA, INC

Published

on

Strategic Asset Leasing Inc., (OTCMKTS: LEAS) is making a major move northbound out of the triple zeroes to recent highs over a penny. The stock is quickly gaining traction among small cap investors and starting to attract some big players. Currently under heavy accumulation LEAS is looking to break out of its current trading range and blaze a path along the likes of Enzolytics or Tesoro and break out into a whole new dimension; LEAS is on a blue-sky breakout well into copper land.  

LEAS has potential to be very big, currently trading at just a $10 million total market valuation the stock has a low float and a large following of investors that is growing very quickly. The Company is looking to go pink current with the Attorney’s letter filed on September 14 and was recently acquired by Dr. Joseph Sinkule, Co-Founder and CEO of PHARMIA focused on the production, marketing, and sales of life-saving drugs which are either “at risk” of being discontinued or in chronic short supply in the United States and Europe. Drugs referred to as “at risk” are those that are not considered highly profitable by the leading pharmaceutical manufacturers’ but are still essential in the treatment of life-threatening diseases. In this latter respect, PHARMIA is primarily focused on a portfolio of products to treat cancer and infectious diseases, and shortages of drugs caused by the coronavirus pandemic. Dr. Sinkule has over 35 years of drug, biologic, and medical device commercialization experience, and this serial entrepreneur is the founder and driving force behind the Company, its growing product portfolio, and financing strategies. He has personally managed over 8 drug and biotech products successfully through FDA approval to market, 5 medical devices and 8 in vitro diagnostics.  

Strategic Asset Leasing Inc., (OTCMKTS: LEAS) is a perfect merger candidate with a clean balance sheet and fairly low float. Microcapdaily reported on LEAS back in 2019 stating at that time on the Company: “Strategic Asset Leasing used to describe itself as a Company that helps businesses and non-profit organizations of all types and sizes throughout Canada and the United States acquire the equipment they need to operate and grow. The Company’s experienced team offers a full array of equipment financing structures and programs for any type of business. 

PHARMIA is focused on the production, marketing, and sales of life-saving drugs which are either “at risk” of being discontinued or in chronic short supply in the United States and Europe. Drugs referred to as “at risk” are those that are not considered highly profitable by the leading pharmaceutical manufacturers’ but are still essential in the treatment of life-threatening diseases. In this latter respect, PHARMIA is primarily focused on a portfolio of products to treat cancer and infectious diseases, and shortages of drugs caused by the coronavirus pandemic. 

To Find out the inside Scoop on LEAS Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

LEAS

Almost 8 in 10 prescriptions filled in the U.S. are for generic drugs. Generic drugs are chemically identical to branded drugs and must meet the same strict standards in order to receive approval from the Food and Drug Administration (FDA) and European Medicines Agency (EMA). Generic drugs cost substantially less than brand name drugs because the manufacturer isn’t required to repeat costly animal and clinical research on ingredients or dosage forms that are already FDA approved for safety and effectiveness. Most people believe that if something costs more, it has to be better quality. In the case of generic drugs, this is not true. The standards for quality are exactly the same for brand name and generic products. PHARMIA puts quality at the forefront of its operations. Healthcare professionals and consumers can be assured that our drugs meet the same standards as branded drugs. 

According to LEAS filings Mammoth Energy Group, Inc. (A Development Stage Company) was incorporated on February 27, 2006 under the laws of the State of Nevada. Prior to its incorporation in Nevada, the Company had been incorporated as Technigen Corporation in Canada. It has had limited operations since its incorporation in the United States. In accordance with Accounting Standards Codification (“ASC”) 915, Development Stage Entities, the Company is considered to be in the development stage. In March of 2013, management decided to change jurisdiction to Wyoming, and to subsequently dissolve the Nevada Corporation. Mammoth Energy Group, Inc. was incorporated in Wyoming by filing Articles of Continuance on March 5, 2013. 

We also reported on LEAS in September 2020 after new CEO Jason Tucker acquired the company from its previous management in February bringing with him valuable Intellectual Property stating: “The Company is developing its flagship Cash App which supports real time tap-2-pay. Stategic has also entered the booming cannabis technology market, is developing 2 i.o.T products including the ‘Safe and Secure Nightlight’ (SSN). Integrated with WIFI, night light, motion sensor, beeper/alarm as well as an indoor air quality control system which connects to the homes furnace filter and link the user through a stand-alone app or integrated into other smart home systems such as Alexa, Nest or Google Home. Strategic also just signed an LOI to acquire a cryptocurrency mining data center including the building, infrastructure, and all mining hardware. The New Jersey based facility is Telecom Industry (ANSI/TIA-942) rated level 2, which exceeds the project’s demands and offers robust protection from physical events.” 

For More on LEAS Subscribe Right Now!

LEAS is making a major move northbound out of the triple zeroes to recent highs over a penny. The stock is quickly gaining traction among small cap investors and starting to attract some big players. Currently under heavy accumulation LEAS is looking to break out of its current trading range and blaze a path along the likes of Enzolytics or Tesoro and break out into a whole new dimension; LEAS is on a blue-sky breakout well into copper land. LEAS has potential to be very big, currently trading at just a $10 million total market valuation the stock has a low float and a large following of investors that is growing very quickly. The Company is looking to go pink current with the Attorney’s letter filed on September 14 and was recently acquired by Dr. Joseph Sinkule, Co-Founder and CEO of PHARMIA focused on the production, marketing, and sales of life-saving drugs which are either “at risk” of being discontinued or in chronic short supply in the United States and Europe. Drugs referred to as “at risk” are those that are not considered highly profitable by the leading pharmaceutical manufacturers’ but are still essential in the treatment of life-threatening diseases. In this latter respect, PHARMIA is primarily focused on a portfolio of products to treat cancer and infectious diseases, and shortages of drugs caused by the coronavirus pandemic. Dr. Sinkule has over 35 years of drug, biologic, and medical device commercialization experience, and this serial entrepreneur is the founder and driving force behind the Company, its growing product portfolio, and financing strategies. He has personally managed over 8 drug and biotech products successfully through FDA approval to market, 5 medical devices and 8 in vitro diagnostics. We will be updating on LEAS when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with LEAS.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in LEAS either long or short and we have not been compensated for this article.

Continue Reading
2 Comments

2 Comments

  1. bonnie

    October 20, 2021 at 11:14 am

    This stock goes up then down cannot figure it out

  2. Geo

    December 10, 2021 at 2:46 pm

    There’s a psychological rule among Hedge fund holders, it is ” sell on the news, buy on rumors.”

Leave a Reply

Your email address will not be published. Required fields are marked *

Featured

MSP Recovery (NASDAQ: LIFW) in the Spotlight: Legal Battles, Luxe Living, and Stock Surge

Published

on

MSP Recovery (NASDAQ: LIFW) has been on quite the rollercoaster ride, defying gravity with over 400% gain since September 14th, 2023 with over 240% of that gain happening this week alone. However, the exact reasons behind this meteoric rise remain elusive. Typically, when a company drops major news, you’d expect an instant stock reaction. But in this case, the last significant update from the company was about a week ago, and it’s questionable whether that news was much on the positive side, yet the stock is still zooming upwards.

Background:

Let’s delve into the nitty-gritty of what MSP Recovery, more prominently known as LifeWallet, is all about. Imagine them as the healthcare financial detectives, diligently sifting through the complexities of medical billing and reimbursements. They specialize in recovering money owed to healthcare providers. If an insurance company owes a hospital for a patient’s treatment, these folks ensure that the hospital gets the rightful compensation. But their innovation doesn’t stop there.

Enter “LifeWallet,” their brainchild—a powerful tool designed to revolutionize healthcare transactions. Picture it as a savvy assistant for healthcare professionals, standing by their side in the hustle and bustle of medical care. LifeWallet’s magic lies in its ability to decipher the complexities of healthcare billing and insurance. It guides doctors and hospitals, helping them navigate the tangled web of who should foot the bill, especially in post-accident treatments. It’s a digital ally ensuring fair compensation and smooth financial transactions in the intricate healthcare landscape.

Subscribe to Microcapdaily.com Right Now by entering your Email in the box below. 

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

MSP is making waves in the healthcare domain with this innovative approach, leveraging data analytics to streamline processes and champion fair compensation for healthcare providers. Much like a rollercoaster ride, their journey promises excitement, surprises, and an undeniable thrill in the world of healthcare finances.

Legal Battles and CEO Extravagnce:

Step back and look at their stock chart—MSP has taken a major hit in value this year, and it’s not without reason. Surprisingly, digging into the company’s operations revealed some unpleasant surprises we hadn’t anticipated. It’s been a rough ride for them.

The company was just recently involved in a class action law suit led by recognized leader in shareholder rights litigation, Robbins LLP. The case revolved around MSP not providing essential information to investors transparently.

There were a number of claims mentioned, here’s a quick list.

  1. MSP didn’t reveal there was an ongoing investigation by the SEC and federal prosecutors.
  2. They gave out financial information to investors that was significantly wrong and deceptive.
  3. When admitting they needed to fix their financial results, they didn’t reveal the full extent of the issues.
  4. MSP couldn’t financially handle the claims they were assigned to manage by a major health and engaged in deceitful actions with said provider
  5. The Registration Statement had lots of wrong or misleading statements and was poorly prepared.
  6. Their Proxy also had false or misleading statements.

It all started on July 31, 2023, where The Miami Herald unveiled significant revelations. Stating the CEO John H. Ruiz has been living quite the lifestyle buying several waterfront mansions in Miami, even an entire Boeing passenger jet.

It’s not surprising the Ruiz’s lifestyle was so extravagant considering LifeWallet was once valued at more than $32 billion, but as you can see the company is now worth a small fraction of that. That said, Ruiz’s expensive lifestyle would be tough to continue.

Then again, on August 1, 2023, the Company made disclosures to the SEC (Form 8-K), confirming The Miami Herald’s findings. The stock took another substantial hit, dropping over 12%. Adding to the unfolding drama. After that, a substantial $67 million lawsuit was filed against the Company on the same day, resulting in an 18% plummet in the stock price.

The narrative continues on! On August 17, 2023, MSP acknowledged a notification letter from Nasdaq’s Listing Qualifications Department. They confirmed the Company’s non-compliance with Nasdaq’s Rule 5250(c)(1) due to a delayed Form 10-Q filing for the period ending June 30, 2023. This revelation caused a 19% stock price drop over two days.

With that said, we’ll bet you’re seriously wondering how could this company could possibly see recovery (pun intended) after all these allegations were laid out.

What happened:

Surprisingly enough, it seems Robbins LLP just recently lost the case against MSP and there was an announcement made on September 13th, 2023 about it. All those allegations have vanished into thin air. It’s baffling how a company with so many strikes against it can seemingly wrap things up so quickly. The whole situation leaves us questioning what’s really going on.

Since the announcement the other week, the company’s valuation has skyrocketed, at some points even peaking at an increase of over 400%. Naturally with that kind of trading action, it’s no surprise day traders are getting in on the action. MSP is trending all over Twitter amongst notable users like @timothysykes, @stockplaymaker1, and @AngryRed316 talking about it.

At this point, it looks like investors are basing their trades more on chart patterns and less on the company’s solid financial footing. MSP didn’t deliver great news in its latest earnings report, showing quite a large net loss of over $400 million. It’s quite likely the allegations had a role to play in this financial blow. The real question is if MSP can get its act together, start making real profits, and avoid a chapter 11. Either way, we’ll continue to follow along to see how things pan out!

We will update you on LIFW when more details emerge, subscribe to Microcapdaily to follow along!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Picture geralt by from Pixabay.com

 

Continue Reading

Featured

VCI Global (NASDAQ: VCIG) Joins Forces with Microsoft Azure OpenAI: A Tech Revolution Unleashed

Published

on

VCI Global (NASDAQ: VCIG) is back on the radar with another significant gain of 84%. We wrote about this company just recently in June, where it popped 156% on the announcement of their “Socializer Messenger”. The company is now teaming up with Microsoft Azure OpenAI through its subsidiary, V Galactech Sdn Bhd. This partnership brings together their AI know-how to reshape the world of business solutions, making waves in the tech scene by using Microsoft Azure OpenAI services.

This collaboration is all about meeting the growing demand for tech advancements that are fast, smooth, and globally connected, helping businesses connect better with their customers. It’s also a boost to VCI Global’s AI consulting skills.

Subscribe to Microcapdaily.com Right Now by entering your Email in the box below. 

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

By tapping into what Microsoft Azure OpenAI offers, VCI Global is jumping into the tech world’s fast lane. They plan to come up with some cool innovations, like Generative Pre-trained Transformer 4 (GPT-4) and Microsoft’s new AI-powered chat tool, Bing Chat Enterprise. Plus, they’ll use Microsoft Azure OpenAI’s cutting-edge AI for their projects, including the super-smart AI-assisted sales platform, robosale software.

https://twitter.com/ShortDaPos/status/1694403174566858783?s=20

Dato’ Victor Hoo, Group Executive Chairman and Chief Executive Officer of VCI Global, is very excited about this partnership. He mentions, “We’re thrilled to dive deep into AI innovations, especially with Microsoft Azure OpenAI. We can’t wait to see how this partnership transforms how businesses connect with customers in the ever-changing tech world. The sky’s the limit, and we’re ready to help our clients ride this AI wave.”

About VCI Global Limited:

VCI Global is a versatile consulting group that’s all about helping businesses with their tech and strategy. They give advice on business strategies, help with investor relations, and provide tech know-how. They mainly work in Malaysia, but they also serve clients in Malaysia, China, Singapore, and the United States, covering a bunch of different industries.

If you want to know more about them, just head to https://v-capital.co/.

About Microsoft Azure Open AI:

Microsoft Azure OpenAI is like a treasure chest of artificial intelligence tools and solutions made to help businesses. They offer everything from AI Services to Machine Learning and AI infrastructure, all aimed at helping businesses make the most of AI for their growth and innovation.

We will update you on VCIG when more details emerge, subscribe to Microcapdaily to follow along!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Picture by Mohamed_hassan from Pixabay

Continue Reading

Featured

Mobilicom (NASDAQ: MOB) Secures Landmark Deal with Top Global Manufacturer

Published

on

Mobilicom (NASDAQ: MOB), a company providing cybersecurity and reliable solutions for drones and robotics secures its largest order to date from Teledyne Technologies Incorporated (NYSE: TDY) – shares rocket 123%. $TDY is one of the world’s largest manufacturers of small-sized drones and robotics.

Overview:
This $19B Tier-1 customer has now incorporated Mobilicom’s SkyHopper PRO into its latest small-sized drone platform. This is yet another testament to Mobilicom’s systems as they have already successfully integrated into 44 design wins by various drone and UAV manufacturers.

Subscribe to Microcapdaily.com Right Now by entering your Email in the box below. 

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

More importantly, Teledyne has made significant progress in transitioning from the design phase to production and commercial sales with the U.S. Department of Defense. The company’s latest purchase order appears to reflect only the beginning of potentially multiple recurring orders as they prepare for their first-ever production order for the U.S. DOD.

“As Teledyne-FLIR continues to win additional orders for its small-sized drone platforms with end users such as the U.S. DOD, other federal agencies, and commercial customers, Mobilicom is well positioned for more sales of its Skyhopper Pro,” stated Mobilicom CEO Oren Elkayam. “We see the sales of these systems to the U.S. DOD, one of the largest and most selective procurers of technology, as a strong testament to the excellence of Mobilicom’s market-leading end-to-end solutions.”

 

About SkyHopper PRO:
The SkyHopper PRO is a communication system for drones that ensures secure data transfer. It offers a number of advantages and customization compared to competitors, here’s a quick overview:

Cybersecurity: Prioritizes cybersecurity, ensuring the secure transfer of data between the drone and the ground control station. This feature helps protect sensitive information and prevents unauthorized access or interference.

Reliability: The system is designed to provide robust and reliable communication even in challenging environments. It supports long-range and non-line-of-sight communication, enabling seamless connectivity between the drone and the ground station, even when obstacles are present.

Versatility: Supports multiple transmission modes, including point-to-point and point-to-multipoint communication. This versatility enables various communication setups, such as multi-drone operations and communication to multiple receivers, enhancing flexibility in drone missions.

Industry Integration: Systems have been integrated into numerous design wins by drone and UAV manufacturers indicating their compatibility and suitability for a wide range of platforms. The proven track record of integration demonstrates the system’s adaptability and reliability.

End-to-End Solution: End-to-end solutions for cybersecurity and robust communication. This comprehensive approach ensures seamless integration, streamlined operations, and enhanced overall performance for drone missions.

About Mobilicom:
Mobilicom is a leading provider of end-to-end cybersecurity and robust solutions for drones and robotics. They focus on serving global manufacturers in these industries, offering patented Mobile Mesh networking technology and a proven portfolio of commercialized products. With a growing high-profile global customer base, including corporations, governments, and the military, Mobilicom stands out for its outstanding security capabilities and performance in harsh environments. They derive revenue from hardware and software sales, licensing fees, and professional support services.

About Teledyne Technologies (NYSE: TDY):
Teledyne Technologies is a global leader known for its innovative solutions in aerospace and defense, environmental sensing, and digital imaging. The company’s success stems from a strong emphasis on research and development, enabling them to introduce cutting-edge technologies and meet customer needs effectively. With a focus on quality and customer satisfaction, Teledyne Technologies has earned a solid reputation in the industry. Strategic acquisitions have further strengthened their capabilities, expanding their product offerings and market reach. Through adaptability and a commitment to delivering value, Teledyne Technologies has established itself as a prominent player in various verticals in multiple industries, ultimately paving the way for the company’s current $19B stature in the market.

We will update you on MOB when more details emerge, subscribe to Microcapdaily to follow along!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Picture by Pexels from Pixabay

 

Continue Reading

Trending

© All rights reserved.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.